We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Pathways Curriculum for Use With WPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00788814
Recruitment Status : Completed
First Posted : November 11, 2008
Last Update Posted : October 17, 2012
Portland State University
Information provided by (Responsible Party):
Dena Hassouneh, Oregon Health and Science University

Brief Summary:
Study to assess the efficacy of a modified Pathways curriculum in treating depressive symptoms in women with physical disabilities.

Condition or disease Intervention/treatment
Depression Behavioral: Pathways

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Women Physical Disability and Depression: Communities Responding Now!
Study Start Date : June 2008
Primary Completion Date : January 2012
Study Completion Date : January 2012

Arm Intervention/treatment
Control group
Behavioral: Pathways
Strength-based curriculum addressing depression in women with with physical disabilities

Primary Outcome Measures :
  1. Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: pre-test, post-test weeks, 12, 18, 24 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Women with physical disability requiring accommodation for major mobility limitations
  • CES-D score of 16 or higher -

Exclusion Criteria:

  • Active suicidality
  • Diagnosis of Schizophrenia, Schizoaffective D/O, Psychosis NOS
  • Currently receiving other psychotherapy -

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00788814

United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97236
Sponsors and Collaborators
Oregon Health and Science University
Portland State University
Principal Investigator: Dena M Hassouneh, PhD Oregon Health and Science University

Responsible Party: Dena Hassouneh, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT00788814     History of Changes
Other Study ID Numbers: 1R01MH079818-01A1 ( U.S. NIH Grant/Contract )
First Posted: November 11, 2008    Key Record Dates
Last Update Posted: October 17, 2012
Last Verified: October 2012

Additional relevant MeSH terms:
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders